Transcranial Magnetic Stimulation (TMS) Treatment for Post-Traumatic Stress

Transcranial Magnetic Stimulation (TMS) Treatment for Post-Traumatic Stress

Brief description of study

Evaluates novel Transcranial Magnetic Stimulation (TMS) methods for the treatment of post-traumatic stress disorder (PTSD) and depressive symptoms to determine which strategies provide the greatest benefit to patients.

Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique FDA-approved for the treatment of major depressive disorder (MDD) and obsessive compulsive disorder (OCD). However, there is growing evidence that a targeted strategy for delivering TMS treatment would yield superior clinical outcomes if it were more tailored to individual neuroanatomy. In this study, we plan to examine whether functional Magnetic Resonance Imaging (fMRI) guided TMS might yield an even greater leap forward in promoting optimal clinical outcomes.

Detailed description of study

The study provides TMS treatment at no cost to participants; no insurance is required. Participation includes 20 sessions of TMS treatment over the course of 7 weeks, clinical interviews with study staff, one fMRI scan, and monthly follow-up phone calls for 6 months post-treatment. 

Compensation for the fMRI visit is provided.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Depression,Post-Traumatic Stress,PTSD,Major Depressive Disorder,MDD,Trauma,Survivor,Veteran,Flashbacks
  • Age: Between 18 Years - 60 Years
  • Gender: All

  • Experiencing symptoms of PTSD and depression 
  • Currently not taking any psychiatric medication
  • Seeking a treatment option

Updated on 16 Jun 2021. Study ID: 826007

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center